$SMID

SMITH MIDLAND CORP

Smith-Midland manufactures, sells, leases, licenses and installs precast concrete products and systems for construction, highway, utility and farming uses. Its customers include general contractors and federal, state and local transportation authorities, primarily in the Mid-Atlantic, Northeastern, Midwestern and Southeastern United States. Products include SlenderWall exterior cladding, Sierra Wall sound and sight barriers, J-J Hooks highway safety barriers, Easi-Set and Easi-Span precast buildings, utility vaults, SoftSound soundwall panels and Beach Prisms erosion-control modules. The company also makes custom and general-purpose precast products. Smith-Midland earns money from product sales, barrier rentals and installation services, and from licensing manufacturing and sales rights for proprietary products. License arrangements typically include an initial fee and royalties, which generally range from 4% to 6% of net sales of the licensed product. The company is headquartered in Midland, Virginia, and operates through subsidiaries with facilities in Virginia, North Carolina and South Carolina.

AlphAI earnings readSecond Quarter 2026 · AUG 14Smith-Midland Reports Second Quarter 2026 Financial Results; Company Reports Increasing Backlog to $57.4 MillionVerdict: mixed

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

2
1
0

No SEC Form 4 filings for $SMID in the last 30 days.

See all $SMID insider activity →

Smith-Midland Reports Third Quarter 2026 Financial Results

SMITH MIDLAND CORP (SMID) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Smith-Midland Reports Third Quarter 2026 Financial Results Record Backlog of $72.4 Million, Up 26% Sequentially and 32% Year-Over-Year MIDLAND, VA – November 16, 2026 – Smith-Midland Corporation (NASDAQ: SMID), a provider of innovative, high-quality proprietary and p

Smith-Midland to Release Third Quarter 2026 Earnings on Monday, November 16

Smith-Midland (SMID) will release Q3 2026 earnings on Nov 16, 2026. The company will also present at the Southwest IDEAS Investor Conference on Nov 19, 2026, led by CEO Ashley Smith and CFO Dominic Hunter. Smith-Midland manufactures precast concrete products for construction, transportation, and utility industries.

SMID sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 3 news stories mentioning SMID (SMITH MIDLAND CORP). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.

Recent SMID coverage spans financial news, earnings and insider activity.

What's driving SMID

AlphAI scores every news story that mentions SMID with an AI model for sentiment and relevance, and aggregates insider trades from SMITH MIDLAND CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SMID

Score
$SMIDMedEarnings

Smith-Midland Reports Third Quarter 2026 Financial Results

SMITH MIDLAND CORP (SMID) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Smith-Midland Reports Third Quarter 2026 Financial Results Record Backlog of $72.4 Million, Up 26% Sequentially and 32% Year-Over-Year MIDLAND, VA – November 16, 2026 – Smith-Midland Corporation (NASDAQ: SMID), a provider of innovative, high-quality proprietary and p

Top Research Reports for Cisco, Shopify & Starbucks

Zacks Research Daily features reports on Cisco (CSCO), Shopify (SHOP), and Starbucks (SBUX). Cisco's shares outperformed its industry, driven by demand in networking, security, and AI infrastructure. Shopify's growth is supported by merchant gains and AI tools, despite competition. Starbucks benefits from improving customer traffic and expanding margins, though restructuring costs are a concern.

Top insider buys and sells disclosed for Friday

Enovis Corp. (ENOV) insiders bought shares near a 52-week low, with CEO Damien McDonald acquiring 13,035 shares at $19.10-$19.16. Atara Biotherapeutics (ATRA) director bought 104,166 shares at $9.60. Smith-Midland Corp. (SMID) insiders also made purchases. Illumina (ILMN) director sold $57.2M in shares near a 52-week high. Caris Life Sciences (CRIS) exec sold $14.8M in shares. Okta (OKTA) CFO sold 80,000 shares. Krystal Biotech (KRY) execs sold shares near a 52-week high.

Related tickers